Cencora, Inc. $COR Shares Sold by Atria Investments Inc

Atria Investments Inc lessened its position in shares of Cencora, Inc. (NYSE:COR) by 7.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 48,761 shares of the company’s stock after selling 3,693 shares during the quarter. Atria Investments Inc’s holdings in Cencora were worth $15,239,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in COR. Norges Bank acquired a new position in Cencora during the second quarter worth about $695,215,000. Mizuho Markets Americas LLC increased its stake in shares of Cencora by 116.4% during the 3rd quarter. Mizuho Markets Americas LLC now owns 212,800 shares of the company’s stock worth $66,506,000 after purchasing an additional 1,511,906 shares in the last quarter. Artisan Partners Limited Partnership purchased a new position in shares of Cencora during the 2nd quarter worth approximately $411,888,000. Vanguard Group Inc. raised its position in shares of Cencora by 5.3% during the 2nd quarter. Vanguard Group Inc. now owns 22,479,041 shares of the company’s stock worth $6,740,340,000 after purchasing an additional 1,125,661 shares during the last quarter. Finally, Viking Global Investors LP lifted its stake in Cencora by 95.0% in the 2nd quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock valued at $624,207,000 after buying an additional 1,013,913 shares in the last quarter. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cencora

In related news, EVP Silvana Battaglia sold 1,677 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $345.00, for a total transaction of $578,565.00. Following the transaction, the executive vice president directly owned 18,796 shares of the company’s stock, valued at approximately $6,484,620. The trade was a 8.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Robert P. Mauch sold 5,096 shares of the stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the sale, the chief executive officer directly owned 66,726 shares of the company’s stock, valued at $23,669,713.98. This trade represents a 7.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 20,316 shares of company stock valued at $7,151,265 over the last quarter. Company insiders own 0.38% of the company’s stock.

Cencora Trading Up 1.6%

Shares of COR stock opened at $365.89 on Thursday. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. Cencora, Inc. has a fifty-two week low of $237.71 and a fifty-two week high of $377.54. The firm’s 50 day moving average price is $346.79 and its two-hundred day moving average price is $327.66. The stock has a market cap of $70.98 billion, a price-to-earnings ratio of 43.98, a price-to-earnings-growth ratio of 1.66 and a beta of 0.68.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. The business had revenue of $85.93 billion for the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter last year, the firm posted $3.73 EPS. On average, analysts anticipate that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, February 13th. Cencora’s payout ratio is currently 28.85%.

Wall Street Analysts Forecast Growth

COR has been the subject of several recent research reports. UBS Group raised their price target on Cencora from $380.00 to $415.00 and gave the stock a “buy” rating in a research report on Friday, November 7th. Wall Street Zen cut Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. Robert W. Baird set a $415.00 target price on shares of Cencora in a report on Tuesday, January 13th. Bank of America decreased their price target on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating on the stock in a research note on Monday, January 5th. Finally, Barclays assumed coverage on shares of Cencora in a research report on Monday, December 8th. They issued an “overweight” rating and a $400.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $396.92.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.